From Financial Modeling Prep: 2025-03-25 12:43:00

Raymond James upgraded HealthEquity (NASDAQ:HQY) to Strong Buy with a new price target of $115, citing confidence in the company’s ability to overcome near-term challenges despite industry-wide fraud risks. Analysts noted increased fraud costs but emphasized it’s a widespread issue. Over 35% of financial institutions report more than 1,000 fraud attempts.

Despite fraud pressures, Raymond James remains bullish on HealthEquity, expecting management to address current issues effectively. Recent 10-K filings confirmed no cybersecurity threats impacting operations. The firm sees strong fundamentals and strategic positioning, viewing current stock levels as an attractive opportunity for long-term investors despite short-term challenges.



Read more at Financial Modeling Prep:: Raymond James Upgrades HealthEquity to Strong Buy …